组织蛋白酶B (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "组织蛋白酶B" in Chinese language version.
refsWebsite
Global rank
Chinese rank
11th place
332nd place
6th place
4th place
1,626th place
1,931st place
18th place
57th place
5th place
12th place
1st place
1st place
archive.org
- Mort JS, Buttle DJ. Cathepsin B. The International Journal of Biochemistry & Cell Biology. May 1997, 29 (5): 715–20. PMID 9251238. doi:10.1016/s1357-2725(96)00152-5.
- Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Human Pathology. August 2000, 31 (8): 931–7. PMID 10987253. doi:10.1053/hupa.2000.9035.
- Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biological Chemistry. September 2005, 386 (9): 931–40. PMID 16164418. S2CID 9038695. doi:10.1515/BC.2005.108.
- Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. The Journal of Pharmacology and Experimental Therapeutics. March 2009, 328 (3): 813–21. PMID 19064719. S2CID 7798381. doi:10.1124/jpet.108.147082.
doi.org
- Chan SJ, San Segundo B, McCormick MB, Steiner DF. Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proceedings of the National Academy of Sciences of the United States of America. October 1986, 83 (20): 7721–5. Bibcode:1986PNAS...83.7721C. PMC 386793
. PMID 3463996. doi:10.1073/pnas.83.20.7721 . - Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene. February 1994, 139 (2): 163–9. PMID 8112600. doi:10.1016/0378-1119(94)90750-1.
- Tong B, Wan B, Wei Z, Wang T, Zhao P, Dou Y, Lv Z, Xia Y, Dai Y. Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis. Clinical and Experimental Immunology. September 2014, 177 (3): 586–97. PMC 4137842 . PMID 24749816. doi:10.1111/cei.12357.
- Lai WF, Chang CH, Tang Y, Bronson R, Tung CH. Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes. Osteoarthritis and Cartilage. March 2004, 12 (3): 239–44. PMID 14972341. doi:10.1016/j.joca.2003.11.005 .
- Ha SD, Ham B, Mogridge J, Saftig P, Lin S, Kim SO. Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm. The Journal of Biological Chemistry. January 2010, 285 (3): 2120–9. PMC 2804368 . PMID 19858192. doi:10.1074/jbc.M109.065813 .
- Yang WE, Ho CC, Yang SF, Lin SH, Yeh KT, Lin CW, Chen MK. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLOS ONE. 2016, 11 (3): e0152165. Bibcode:2016PLoSO..1152165Y. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165 .
- Qian F, Frankfater A, Chan SJ, Steiner DF. The structure of the mouse cathepsin B gene and its putative promoter. DNA and Cell Biology. April 1991, 10 (3): 159–68. PMID 2012677. doi:10.1089/dna.1991.10.159.
- Mort JS, Buttle DJ. Cathepsin B. The International Journal of Biochemistry & Cell Biology. May 1997, 29 (5): 715–20. PMID 9251238. doi:10.1016/s1357-2725(96)00152-5.
- Alapati K, Kesanakurti D, Rao JS, Dasari VR. uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells. Stem Cell Research. May 2014, 12 (3): 716–29. PMC 4061617 . PMID 24699410. doi:10.1016/j.scr.2014.02.008.
- Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Human Pathology. August 2000, 31 (8): 931–7. PMID 10987253. doi:10.1053/hupa.2000.9035.
- Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLoS ONE. 2016-03-31, 11 (3) [2022-09-12]. ISSN 1932-6203. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165. （原始内容存档于2022-09-12）.
- Fais S. Cannibalism: a way to feed on metastatic tumors. Cancer Letters. December 2007, 258 (2): 155–64. PMID 17977647. doi:10.1016/j.canlet.2007.09.014.
- Lambeth, Tyler R.; Dai, Zhefu; Zhang, Yong; Julian, Ryan R. A two-trick pony: lysosomal protease cathepsin B possesses surprising ligase activity. RSC Chemical Biology. 2021, 2 (2): 606–611. ISSN 2633-0679. PMC 8291735 . PMID 34291207. doi:10.1039/D0CB00224K （英语）.
- Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J. Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity. Oncotarget. August 2015, 6 (22): 19027–42. PMC 4662473 . PMID 25848918. doi:10.18632/oncotarget.3699.
- Bian B, Mongrain S, Cagnol S, Langlois MJ, Boulanger J, Bernatchez G, Carrier JC, Boudreau F, Rivard N. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis. Molecular Carcinogenesis. May 2016, 55 (5): 671–87. PMC 4832390 . PMID 25808857. doi:10.1002/mc.22312.
- Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. September 2014, 33 (36): 4474–84. PMC 4139469 . PMID 24077280. doi:10.1038/onc.2013.395.
- Bao W, Fan Q, Luo X, Cheng WW, Wang YD, Li ZN, Chen XL, Wu D. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer. Oncology Reports. August 2013, 30 (2): 723–30. PMID 23708264. doi:10.3892/or.2013.2496 .
- Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. The American Journal of Pathology. December 2012, 181 (6): 2202–16. PMID 23063511. doi:10.1016/j.ajpath.2012.08.027 .
- Ruan J, Zheng H, Rong X, Rong X, Zhang J, Fang W, Zhao P, Luo R. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients. Molecular Cancer. 20 February 2016, 15: 17. PMC 4761221 . PMID 26896959. doi:10.1186/s12943-016-0503-9.
- Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, Janke E, Lubejko ST, Greig NH, Mattison JA, Duzel E, van Praag H. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function. Cell Metabolism. June 2016, 24 (2): 332–40. PMC 6029441 . PMID 27345423. doi:10.1016/j.cmet.2016.05.025.
- Houseweart MK, Pennacchio LA, Vilaythong A, Peters C, Noebels JL, Myers RM. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). Journal of Neurobiology. September 2003, 56 (4): 315–27. PMID 12918016. doi:10.1002/neu.10253.
- Ni H, Ren SY, Zhang LL, Sun Q, Tian T, Feng X. Expression profiles of hippocampal regenerative sprouting-related genes and their regulation by E-64d in a developmental rat model of penicillin-induced recurrent epilepticus. Toxicology Letters. February 2013, 217 (2): 162–9. PMID 23266720. doi:10.1016/j.toxlet.2012.12.010.
- Hook GR, Yu J, Sipes N, Pierschbacher MD, Hook V, Kindy MS. The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury. Journal of Neurotrauma. March 2014, 31 (5): 515–29. PMC 3934599 . PMID 24083575. doi:10.1089/neu.2013.2944.
- Luo CL, Chen XP, Yang R, Sun YX, Li QQ, Bao HJ, Cao QQ, Ni H, Qin ZH, Tao LY. Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway. Journal of Neuroscience Research. October 2010, 88 (13): 2847–58. PMID 20653046. S2CID 2977933. doi:10.1002/jnr.22453.
- Yoshida M, Yamashima T, Zhao L, Tsuchiya K, Kohda Y, Tonchev AB, Matsuda M, Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathologica. September 2002, 104 (3): 267–72. PMID 12172912. S2CID 10913622. doi:10.1007/s00401-002-0554-4.
- Tsuchiya K, Kohda Y, Yoshida M, Zhao L, Ueno T, Yamashita J, Yoshioka T, Kominami E, Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Experimental Neurology. February 1999, 155 (2): 187–94. PMID 10072294. S2CID 22548769. doi:10.1006/exnr.1998.6988.
- Tsubokawa T, Yamaguchi-Okada M, Calvert JW, Solaroglu I, Shimamura N, Yata K, Zhang JH. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats. Journal of Neuroscience Research. September 2006, 84 (4): 832–40. PMID 16802320. S2CID 24194809. doi:10.1002/jnr.20977.
- Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C, Pfister HW, Fontana A, Hammerschmidt S, Koedel U. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. Journal of Immunology. November 2011, 187 (10): 5440–51. PMID 22003197. doi:10.4049/jimmunol.1100790 .
- Hook VY, Kindy M, Hook G. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. The Journal of Biological Chemistry. March 2008, 283 (12): 7745–53. PMID 18184658. doi:10.1074/jbc.m708362200 .
- Hook V, Kindy M, Hook G. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biological Chemistry. February 2007, 388 (2): 247–52. PMID 17261088. S2CID 34617103. doi:10.1515/bc.2007.027.
- Hook G, Hook VY, Kindy M. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biological Chemistry. September 2007, 388 (9): 979–83. PMID 17696783. S2CID 84162059. doi:10.1515/BC.2007.117.
- Hook VY, Kindy M, Reinheckel T, Peters C, Hook G. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochemical and Biophysical Research Communications. August 2009, 386 (2): 284–8. PMC 2753505 . PMID 19501042. doi:10.1016/j.bbrc.2009.05.131.
- Hook G, Hook V, Kindy M. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. Journal of Alzheimer's Disease. 2011, 26 (2): 387–408. PMC 4317342 . PMID 21613740. doi:10.3233/JAD-2011-110101.
- Kindy MS, Yu J, Zhu H, El-Amouri SS, Hook V, Hook GR. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. Journal of Alzheimer's Disease. 2012, 29 (4): 827–40. PMC 4309289 . PMID 22337825. doi:10.3233/JAD-2012-111604.
- Hook G, Yu J, Toneff T, Kindy M, Hook V. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. Journal of Alzheimer's Disease. 2014, 41 (1): 129–49. PMC 4059604 . PMID 24595198. doi:10.3233/JAD-131370.
- Shi C, Zheng DD, Wu FM, Liu J, Xu J. The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide. Neurochemical Research. February 2012, 37 (2): 298–306. PMID 21952928. S2CID 5744771. doi:10.1007/s11064-011-0612-1.
- Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biological Chemistry. September 2005, 386 (9): 931–40. PMID 16164418. S2CID 9038695. doi:10.1515/BC.2005.108.
- Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. The Journal of Pharmacology and Experimental Therapeutics. March 2009, 328 (3): 813–21. PMID 19064719. S2CID 7798381. doi:10.1124/jpet.108.147082.
- Tandon RK. Tropical pancreatitis. Journal of Gastroenterology. January 2007,. 42 Suppl 17 (Suppl 17): 141–7. PMID 17238044. S2CID 2796833. doi:10.1007/s00535-006-1930-y.
- van der Stappen JW, Williams AC, Maciewicz RA, Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. International Journal of Cancer. August 1996, 67 (4): 547–54. PMID 8759615. doi:10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4 .
- Pavlova A, Björk I. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Biochemistry. September 2003, 42 (38): 11326–33. PMID 14503883. doi:10.1021/bi030119v.
- Estrada S, Nycander M, Hill NJ, Craven CJ, Waltho JP, Björk I. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L. Biochemistry. May 1998, 37 (20): 7551–60. PMID 9585570. doi:10.1021/bi980026r.
- Pol E, Björk I. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases. Protein Science. September 2001, 10 (9): 1729–38. PMC 2253190 . PMID 11514663. doi:10.1110/ps.11901.
- Mai J, Finley RL, Waisman DM, Sloane BF. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. The Journal of Biological Chemistry. April 2000, 275 (17): 12806–12. PMID 10777578. doi:10.1074/jbc.275.17.12806 .
- Hurley EA, Thorley-Lawson DA. B cell activation and the establishment of Epstein-Barr virus latency. The Journal of Experimental Medicine. December 1988, 168 (6): 2059–75. PMC 2189139 . PMID 2848918. doi:10.1084/jem.168.6.2059.
- Murata, Mitsuo; Miyashita, Satsuki; Yokoo, Chihiro; Tamai, Musaharu; Hanada, Kazunori; Hatayama, Katsuo; Towatari, Takae; Nikawa, Takeshi; Katunuma, Nobuhiko. Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro. FEBS Letters. 1991-03-25, 280 (2). doi:10.1016/0014-5793(91)80318-W （英语）.
ensembl.org
May2017.archive.ensembl.org
harvard.edu
ui.adsabs.harvard.edu
- Chan SJ, San Segundo B, McCormick MB, Steiner DF. Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proceedings of the National Academy of Sciences of the United States of America. October 1986, 83 (20): 7721–5. Bibcode:1986PNAS...83.7721C. PMC 386793 . PMID 3463996. doi:10.1073/pnas.83.20.7721 .
- Yang WE, Ho CC, Yang SF, Lin SH, Yeh KT, Lin CW, Chen MK. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLOS ONE. 2016, 11 (3): e0152165. Bibcode:2016PLoSO..1152165Y. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165 .
nih.gov
ncbi.nlm.nih.gov
- Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine.
- Mouse PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine.
- Sloane BF. Cathepsin B and cystatins: evidence for a role in cancer progression. Seminars in Cancer Biology. April 1990, 1 (2): 137–52. PMID 2103490.
- Chan SJ, San Segundo B, McCormick MB, Steiner DF. Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proceedings of the National Academy of Sciences of the United States of America. October 1986, 83 (20): 7721–5. Bibcode:1986PNAS...83.7721C. PMC 386793 . PMID 3463996. doi:10.1073/pnas.83.20.7721 .
- Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene. February 1994, 139 (2): 163–9. PMID 8112600. doi:10.1016/0378-1119(94)90750-1.
- Tong B, Wan B, Wei Z, Wang T, Zhao P, Dou Y, Lv Z, Xia Y, Dai Y. Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis. Clinical and Experimental Immunology. September 2014, 177 (3): 586–97. PMC 4137842 . PMID 24749816. doi:10.1111/cei.12357.
- Lai WF, Chang CH, Tang Y, Bronson R, Tung CH. Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes. Osteoarthritis and Cartilage. March 2004, 12 (3): 239–44. PMID 14972341. doi:10.1016/j.joca.2003.11.005 .
- Ha SD, Ham B, Mogridge J, Saftig P, Lin S, Kim SO. Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm. The Journal of Biological Chemistry. January 2010, 285 (3): 2120–9. PMC 2804368 . PMID 19858192. doi:10.1074/jbc.M109.065813 .
- Yang WE, Ho CC, Yang SF, Lin SH, Yeh KT, Lin CW, Chen MK. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLOS ONE. 2016, 11 (3): e0152165. Bibcode:2016PLoSO..1152165Y. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165 .
- Qian F, Frankfater A, Chan SJ, Steiner DF. The structure of the mouse cathepsin B gene and its putative promoter. DNA and Cell Biology. April 1991, 10 (3): 159–68. PMID 2012677. doi:10.1089/dna.1991.10.159.
- Entrez Gene: CTSB cathepsin B.
- Kirschke H, Barrett AJ, Rawlings ND. Proteinases 1: lysosomal cysteine proteinases. Protein Profile. 1995, 2 (14): 1581–643. PMID 8771190.
- Mort JS, Buttle DJ. Cathepsin B. The International Journal of Biochemistry & Cell Biology. May 1997, 29 (5): 715–20. PMID 9251238. doi:10.1016/s1357-2725(96)00152-5.
- Alapati K, Kesanakurti D, Rao JS, Dasari VR. uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells. Stem Cell Research. May 2014, 12 (3): 716–29. PMC 4061617 . PMID 24699410. doi:10.1016/j.scr.2014.02.008.
- Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Human Pathology. August 2000, 31 (8): 931–7. PMID 10987253. doi:10.1053/hupa.2000.9035.
- Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLoS ONE. 2016-03-31, 11 (3) [2022-09-12]. ISSN 1932-6203. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165. （原始内容存档于2022-09-12）.
- Fais S. Cannibalism: a way to feed on metastatic tumors. Cancer Letters. December 2007, 258 (2): 155–64. PMID 17977647. doi:10.1016/j.canlet.2007.09.014.
- Lambeth, Tyler R.; Dai, Zhefu; Zhang, Yong; Julian, Ryan R. A two-trick pony: lysosomal protease cathepsin B possesses surprising ligase activity. RSC Chemical Biology. 2021, 2 (2): 606–611. ISSN 2633-0679. PMC 8291735 . PMID 34291207. doi:10.1039/D0CB00224K （英语）.
- Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J. Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity. Oncotarget. August 2015, 6 (22): 19027–42. PMC 4662473 . PMID 25848918. doi:10.18632/oncotarget.3699.
- Bian B, Mongrain S, Cagnol S, Langlois MJ, Boulanger J, Bernatchez G, Carrier JC, Boudreau F, Rivard N. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis. Molecular Carcinogenesis. May 2016, 55 (5): 671–87. PMC 4832390 . PMID 25808857. doi:10.1002/mc.22312.
- Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. September 2014, 33 (36): 4474–84. PMC 4139469 . PMID 24077280. doi:10.1038/onc.2013.395.
- Bao W, Fan Q, Luo X, Cheng WW, Wang YD, Li ZN, Chen XL, Wu D. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer. Oncology Reports. August 2013, 30 (2): 723–30. PMID 23708264. doi:10.3892/or.2013.2496 .
- Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. The American Journal of Pathology. December 2012, 181 (6): 2202–16. PMID 23063511. doi:10.1016/j.ajpath.2012.08.027 .
- Ruan J, Zheng H, Rong X, Rong X, Zhang J, Fang W, Zhao P, Luo R. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients. Molecular Cancer. 20 February 2016, 15: 17. PMC 4761221 . PMID 26896959. doi:10.1186/s12943-016-0503-9.
- Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, Janke E, Lubejko ST, Greig NH, Mattison JA, Duzel E, van Praag H. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function. Cell Metabolism. June 2016, 24 (2): 332–40. PMC 6029441 . PMID 27345423. doi:10.1016/j.cmet.2016.05.025.
- Houseweart MK, Pennacchio LA, Vilaythong A, Peters C, Noebels JL, Myers RM. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). Journal of Neurobiology. September 2003, 56 (4): 315–27. PMID 12918016. doi:10.1002/neu.10253.
- Ni H, Ren SY, Zhang LL, Sun Q, Tian T, Feng X. Expression profiles of hippocampal regenerative sprouting-related genes and their regulation by E-64d in a developmental rat model of penicillin-induced recurrent epilepticus. Toxicology Letters. February 2013, 217 (2): 162–9. PMID 23266720. doi:10.1016/j.toxlet.2012.12.010.
- Hook GR, Yu J, Sipes N, Pierschbacher MD, Hook V, Kindy MS. The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury. Journal of Neurotrauma. March 2014, 31 (5): 515–29. PMC 3934599 . PMID 24083575. doi:10.1089/neu.2013.2944.
- Luo CL, Chen XP, Yang R, Sun YX, Li QQ, Bao HJ, Cao QQ, Ni H, Qin ZH, Tao LY. Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway. Journal of Neuroscience Research. October 2010, 88 (13): 2847–58. PMID 20653046. S2CID 2977933. doi:10.1002/jnr.22453.
- Yoshida M, Yamashima T, Zhao L, Tsuchiya K, Kohda Y, Tonchev AB, Matsuda M, Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathologica. September 2002, 104 (3): 267–72. PMID 12172912. S2CID 10913622. doi:10.1007/s00401-002-0554-4.
- Tsuchiya K, Kohda Y, Yoshida M, Zhao L, Ueno T, Yamashita J, Yoshioka T, Kominami E, Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Experimental Neurology. February 1999, 155 (2): 187–94. PMID 10072294. S2CID 22548769. doi:10.1006/exnr.1998.6988.
- Tsubokawa T, Yamaguchi-Okada M, Calvert JW, Solaroglu I, Shimamura N, Yata K, Zhang JH. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats. Journal of Neuroscience Research. September 2006, 84 (4): 832–40. PMID 16802320. S2CID 24194809. doi:10.1002/jnr.20977.
- Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C, Pfister HW, Fontana A, Hammerschmidt S, Koedel U. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. Journal of Immunology. November 2011, 187 (10): 5440–51. PMID 22003197. doi:10.4049/jimmunol.1100790 .
- Hook VY, Kindy M, Hook G. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. The Journal of Biological Chemistry. March 2008, 283 (12): 7745–53. PMID 18184658. doi:10.1074/jbc.m708362200 .
- Hook V, Kindy M, Hook G. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biological Chemistry. February 2007, 388 (2): 247–52. PMID 17261088. S2CID 34617103. doi:10.1515/bc.2007.027.
- Hook G, Hook VY, Kindy M. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biological Chemistry. September 2007, 388 (9): 979–83. PMID 17696783. S2CID 84162059. doi:10.1515/BC.2007.117.
- Hook VY, Kindy M, Reinheckel T, Peters C, Hook G. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochemical and Biophysical Research Communications. August 2009, 386 (2): 284–8. PMC 2753505 . PMID 19501042. doi:10.1016/j.bbrc.2009.05.131.
- Hook G, Hook V, Kindy M. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. Journal of Alzheimer's Disease. 2011, 26 (2): 387–408. PMC 4317342 . PMID 21613740. doi:10.3233/JAD-2011-110101.
- Kindy MS, Yu J, Zhu H, El-Amouri SS, Hook V, Hook GR. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. Journal of Alzheimer's Disease. 2012, 29 (4): 827–40. PMC 4309289 . PMID 22337825. doi:10.3233/JAD-2012-111604.
- Hook G, Yu J, Toneff T, Kindy M, Hook V. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. Journal of Alzheimer's Disease. 2014, 41 (1): 129–49. PMC 4059604 . PMID 24595198. doi:10.3233/JAD-131370.
- Shi C, Zheng DD, Wu FM, Liu J, Xu J. The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide. Neurochemical Research. February 2012, 37 (2): 298–306. PMID 21952928. S2CID 5744771. doi:10.1007/s11064-011-0612-1.
- Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biological Chemistry. September 2005, 386 (9): 931–40. PMID 16164418. S2CID 9038695. doi:10.1515/BC.2005.108.
- Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. The Journal of Pharmacology and Experimental Therapeutics. March 2009, 328 (3): 813–21. PMID 19064719. S2CID 7798381. doi:10.1124/jpet.108.147082.
- Tandon RK. Tropical pancreatitis. Journal of Gastroenterology. January 2007,. 42 Suppl 17 (Suppl 17): 141–7. PMID 17238044. S2CID 2796833. doi:10.1007/s00535-006-1930-y.
- van der Stappen JW, Williams AC, Maciewicz RA, Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. International Journal of Cancer. August 1996, 67 (4): 547–54. PMID 8759615. doi:10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4 .
- Pavlova A, Björk I. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Biochemistry. September 2003, 42 (38): 11326–33. PMID 14503883. doi:10.1021/bi030119v.
- Estrada S, Nycander M, Hill NJ, Craven CJ, Waltho JP, Björk I. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L. Biochemistry. May 1998, 37 (20): 7551–60. PMID 9585570. doi:10.1021/bi980026r.
- Pol E, Björk I. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases. Protein Science. September 2001, 10 (9): 1729–38. PMC 2253190 . PMID 11514663. doi:10.1110/ps.11901.
- Mai J, Finley RL, Waisman DM, Sloane BF. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. The Journal of Biological Chemistry. April 2000, 275 (17): 12806–12. PMID 10777578. doi:10.1074/jbc.275.17.12806 .
- Hurley EA, Thorley-Lawson DA. B cell activation and the establishment of Epstein-Barr virus latency. The Journal of Experimental Medicine. December 1988, 168 (6): 2059–75. PMC 2189139 . PMID 2848918. doi:10.1084/jem.168.6.2059.
semanticscholar.org
api.semanticscholar.org
- Luo CL, Chen XP, Yang R, Sun YX, Li QQ, Bao HJ, Cao QQ, Ni H, Qin ZH, Tao LY. Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway. Journal of Neuroscience Research. October 2010, 88 (13): 2847–58. PMID 20653046. S2CID 2977933. doi:10.1002/jnr.22453.
- Yoshida M, Yamashima T, Zhao L, Tsuchiya K, Kohda Y, Tonchev AB, Matsuda M, Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathologica. September 2002, 104 (3): 267–72. PMID 12172912. S2CID 10913622. doi:10.1007/s00401-002-0554-4.
- Tsuchiya K, Kohda Y, Yoshida M, Zhao L, Ueno T, Yamashita J, Yoshioka T, Kominami E, Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Experimental Neurology. February 1999, 155 (2): 187–94. PMID 10072294. S2CID 22548769. doi:10.1006/exnr.1998.6988.
- Tsubokawa T, Yamaguchi-Okada M, Calvert JW, Solaroglu I, Shimamura N, Yata K, Zhang JH. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats. Journal of Neuroscience Research. September 2006, 84 (4): 832–40. PMID 16802320. S2CID 24194809. doi:10.1002/jnr.20977.
- Hook V, Kindy M, Hook G. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biological Chemistry. February 2007, 388 (2): 247–52. PMID 17261088. S2CID 34617103. doi:10.1515/bc.2007.027.
- Hook G, Hook VY, Kindy M. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biological Chemistry. September 2007, 388 (9): 979–83. PMID 17696783. S2CID 84162059. doi:10.1515/BC.2007.117.
- Shi C, Zheng DD, Wu FM, Liu J, Xu J. The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide. Neurochemical Research. February 2012, 37 (2): 298–306. PMID 21952928. S2CID 5744771. doi:10.1007/s11064-011-0612-1.
- Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biological Chemistry. September 2005, 386 (9): 931–40. PMID 16164418. S2CID 9038695. doi:10.1515/BC.2005.108.
- Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. The Journal of Pharmacology and Experimental Therapeutics. March 2009, 328 (3): 813–21. PMID 19064719. S2CID 7798381. doi:10.1124/jpet.108.147082.
- Tandon RK. Tropical pancreatitis. Journal of Gastroenterology. January 2007,. 42 Suppl 17 (Suppl 17): 141–7. PMID 17238044. S2CID 2796833. doi:10.1007/s00535-006-1930-y.
web.archive.org
- Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLoS ONE. 2016-03-31, 11 (3) [2022-09-12]. ISSN 1932-6203. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165. （原始内容存档于2022-09-12）.
wiley.com
doi.wiley.com
- Murata, Mitsuo; Miyashita, Satsuki; Yokoo, Chihiro; Tamai, Musaharu; Hanada, Kazunori; Hatayama, Katsuo; Towatari, Takae; Nikawa, Takeshi; Katunuma, Nobuhiko. Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro. FEBS Letters. 1991-03-25, 280 (2). doi:10.1016/0014-5793(91)80318-W （英语）.
worldcat.org
- Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLoS ONE. 2016-03-31, 11 (3) [2022-09-12]. ISSN 1932-6203. PMC 4816521 . PMID 27031837. doi:10.1371/journal.pone.0152165. （原始内容存档于2022-09-12）.
- Lambeth, Tyler R.; Dai, Zhefu; Zhang, Yong; Julian, Ryan R. A two-trick pony: lysosomal protease cathepsin B possesses surprising ligase activity. RSC Chemical Biology. 2021, 2 (2): 606–611. ISSN 2633-0679. PMC 8291735 . PMID 34291207. doi:10.1039/D0CB00224K （英语）.